Breast cancer risk genes—association analysis in more than 113,000 women Breast Cancer Association Consortium New England Journal of Medicine 384 (5), 428-439, 2021 | 842 | 2021 |
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 407 | 2020 |
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 177 | 2020 |
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer MA Ferreira, ER Gamazon, F Al-Ejeh, K Aittomäki, IL Andrulis, ... Nature communications 10 (1), 1741, 2019 | 138 | 2019 |
Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes N Mavaddat, L Dorling, S Carvalho, J Allen, A González-Neira, R Keeman, ... JAMA oncology 8 (3), e216744-e216744, 2022 | 100 | 2022 |
Genome-wide association study of germline variants and breast cancer-specific mortality Br J Cancer, 2019 | 75 | 2019 |
Breast cancer polygenic risk score and contralateral breast cancer risk I Kramer, MJ Hooning, N Mavaddat, M Hauptmann, R Keeman, ... The American Journal of Human Genetics 107 (5), 837-848, 2020 | 67 | 2020 |
Neuroprotective effects of astaxanthin in a rat model of spinal cord injury JM Masoudi A1, Dargahi L2, Abbaszadeh F2, Pourgholami MH3, Asgari A4 ... Behav Brain Res. 23 (329), 104-110, 2017 | 62* | 2017 |
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study SC Dixon-Suen, SJ Lewis, RM Martin, DR English, T Boyle, GG Giles, ... British journal of sports medicine 56 (20), 1157-1170, 2022 | 52 | 2022 |
Decreased expression of proapoptotic genes caspase-8-and BCL2-associated agonist of cell death (BAD) in ovarian cancer N Borhani, M Manoochehri, SS Gargari, MG Novin, A Mansouri, ... Clinical Ovarian and Other Gynecologic Cancer 7 (1-2), 18-23, 2014 | 50 | 2014 |
Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status H Feng, A Gusev, B Pasaniuc, L Wu, J Long, Z Abu‐full, K Aittomäki, ... Genetic epidemiology 44 (5), 442-468, 2020 | 49 | 2020 |
Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer M Manoochehri, A Karbasi, M Bandehpour, B Kazemi Pathology & Oncology Research 20, 301-307, 2014 | 49 | 2014 |
Breast cancer risks associated with missense variants in breast cancer susceptibility genes L Dorling, S Carvalho, J Allen, MT Parsons, C Fortuno, A González-Neira, ... Genome medicine 14 (1), 51, 2022 | 44 | 2022 |
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis M Escala-Garcia, J Abraham, IL Andrulis, H Anton-Culver, V Arndt, ... Nature communications 11 (1), 312, 2020 | 44 | 2020 |
Tissue-Specific Down-Regulation of the Long Non-Coding RNAs PCAT18 and LINC01133 in Gastric Cancer Development K Foroughi, M Amini, A Atashi, H Mahmoodzadeh, U Hamann, ... Int. J. Mol. Sci. 19 (12), 2018 | 44 | 2018 |
Prediction and clinical utility of a contralateral breast cancer risk model D Giardiello, EW Steyerberg, M Hauptmann, MA Adank, D Akdeniz, ... Breast cancer research 21, 1-13, 2019 | 42 | 2019 |
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer G Figlioli, M Bogliolo, I Catucci, L Caleca, SV Lasheras, R Pujol, JI Kiiski, ... NPJ breast cancer 5 (1), 38, 2019 | 40 | 2019 |
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers EA Moskalev, P Jandaghi, M Fallah, M Manoochehri, SK Botla, ... Oncotarget 6 (6), 4418, 2015 | 35 | 2015 |
Common variants in breast cancer risk loci predispose to distinct tumor subtypes TU Ahearn, H Zhang, K Michailidou, RL Milne, MK Bolla, J Dennis, ... Breast Cancer Research 24, 1-13, 2022 | 34 | 2022 |
SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis M Manoochehri, Y Wu, NA Giese, O Strobel, S Kutschmann, F Haller, ... Molecular Oncology 14 (6), 1252-1267, 2020 | 33 | 2020 |